McGlinn Cancer Institute

West Reading, Pennsylvania 19611-2143

2 studies enrolling now · 2 studies all time

What they study most

B Cell Lymphoma, HR+/HER2- Breast Cancer, Mantle Cell Lymphoma

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) — Recruiting now